Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study

PHASE3CompletedINTERVENTIONAL
Enrollment

269

Participants

Timeline

Start Date

November 13, 2008

Primary Completion Date

April 22, 2010

Study Completion Date

April 22, 2010

Conditions
ADHD
Interventions
DRUG

Lisdexamfetamine Dimesylate (LDX)

optimal dose of 30, 50 or 70 mg once daily

Trial Locations (45)

10549

Bioscience Research, LLC, Mount Kisco

15213

Youth and Family Research Program/WPIC ADHD Research Program, Pittsburgh

19139

CRI Worldwide, Philadelphia

20170

Neuroscience, Inc., Herndon

23112

Dominion Clinical Research, Midlothian

27707

Triangle Neuropsychiatry, PLLC, Durham

30060

Northwest Behavioral Research Center, Marietta

30308

Atlanta Center for Medical Research, Atlanta

32216

Clinical Neuroscience Solutions, Inc., Jacksonville

32607

Sarkis Clinical Trials, Gainesville

32806

Clinical Neuroscience Solutions, Inc., Orlando

33013

Amedica Research Institute, Inc., Hialeah

33143

Miami Research Associates, South Miami

33407

Janus Center for Psychiatric Research, West Palm Beach

34208

Florida Clinical Research Center, LLC, Bradenton

38119

CNS Healthcare, Memphis

42003

Four Rivers Clinical Research, Inc., Paducah

42301

Pedia Research LLC., Owensboro

44106

University Hospitals of Cleveland Division of Child & Adolescent Psychiatry, Cleveland

47802

Clinco Inc., Terre Haute

48085

Bart Sangal, Troy

58104

Innovis Health/Odyssey Research, Fargo

60048

Capstone Clinical Research, Libertyville

66211

Psychiatric Associates, Overland Park

66212

Vince and Associates Clinical Research, Inc., Overland Park

67114

CIENTIFICA, Inc. at Prairie View, Newton

70114

Louisiana Research Associates, Inc., New Orleans

72205

Clinical Study Centers, LLC, Little Rock

73103

IPS Research Company, Oklahoma City

77007

Bayou City Research, Ltd., Houston

77090

Red Oak Psychiatry Associates P.A., Houston

78247

ADHD Clinic of San Antonio, San Antonio

78756

Future Search Trials, Austin

89128

Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas

90274

Penninsula Research Associates, Inc., Rolling Hills Estates

92108

Psychiatric Centers at San Diego (PCSD-Feighner Research Institute), San Diego

92243

Valley Clinical Research, Inc., El Centro

92595

Elite Clinical Trials, Inc., Wildomar

97210

Summit Research Network, Portland

97301

OCCI, INC (Oregon Center for Clinical Investigations, Inc.), Salem

97401

OCCI, Eugene

98004

Northwest Clinical Research Center, Bellevue

08755

Children's Specialized Hospital, Toms River

05401

Vermont Clinical Study Center, Burlington

05091

Neuropsychiatric Associates, Woodstock

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY

NCT00764868 - Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study | Biotech Hunter | Biotech Hunter